Infectious disease test kit DV101-0 series
SARS-COV-2clinicalpharyngeal

infectious disease test kit
infectious disease test kit
Add to favorites
Compare this product
 

Characteristics

Applications
for infectious diseases
Micro-organism
SARS-COV-2
Sample type
clinical, pharyngeal
Analysis mode
for RT-PCR
Result display time

60 min

Description

This real-time RT-PCR kit is intended for detection of ORF1ab and N genes from SARS-CoV-2 and for in vitro auxiliary diagnosis or emergency use of diagnosis of SARS-CoV-2 virus infection. The kit has a set of negative control, positive control and internal control. It has received CE mark. Highlights • High sensitivity: Limit of detection (LoD) of 0.5 copies/μl. • High specificity: Proprietary Triple Antibody Blocking-based Hot Start Technology. No cross reactivity with HCoV-HKU1, HCoV-229E, HCoV-OC43 and HCoV-NL63. • Triplex RT-qPCR: Dual target assay for ORF1ab and N genes and an internal control gene. • Minimized contamination : dUTP/ UNG used. Instruments Validated Instruments in-house: ABI 7500 Real-Time PCR instrument Instruments used by customers with revised interpretation for test results: ABI QuantStudio 3, Bio-Rad CFX96. Sample Types bronchoalveolar lavage specimens Clinical Applications Up to 600,000 reactions of real time RT-PCR for SARS-CoV-2 detection have been successfully applied in clinical diagnosis with our key components. Storage Store the kit at -20±5℃ away from light for 12 months. Shipping Ship the kit at low temperature. Dry ice should be used for long-distance shipping. Avoid repeated freeze-thaw cycles (freeze-thaw cycles should be fewer than 10).

Catalogs

No catalogs are available for this product.

See all of TransGen Biotech Co.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.